Abstract:G protein-coupled receptors (GPCRs) represent the largest family of membrane proteins and are important drug targets. GPCRs are allosteric machines that transduce an extracellular signal to the cell by activating heterotrimeric G proteins. Herein, we summarize the recent advancements in the molecular activation mechanism of the c-aminobutyric acid type B (GABAB) and metabotropic glutamate (mGlu) receptors, the most important class C GPCRs that modulate synaptic transmission in the brain. Both are mandatory dimers, this quaternary structure being needed for their function The structures of these receptors in different conformations and in complexes with G proteins have revealed their asymmetric activation. This asymmetry is further highlighted by the recent discovery of mGlu heterodimers, where the eight mGlu subunits can form specific and functional heterodimers. Finally, the development of allosteric modulators has revealed new possibilities for regulating the function of these receptors by targeting the transmembrane dimer interface. This family of receptors never ceases to astonish and serve as models to better understand the diversity and asymmetric functioning of GPCRs. NEW & NOTEWORTHY c-aminobutyric acid type B (GABAB) and metabotropic glutamate (mGlu) receptors form constitutive dimers, which are required for their function. They serve as models to better understand the diversity and activation of G protein-coupled receptors (GPCRs). The structures of these receptors in different conformations and in complexes with G proteins have revealed their asymmetric activation. This asymmetry is further highlighted by the recent discovery of specific and functional mGlu heterodimers. Allosteric modulators can be developed to target the transmembrane interface and modulate the asymmetry.

Unique Pharmacology of mGluR homo- and heterodimers

Structural Basis of Orientated Asymmetry in a Mglu Heterodimer

Elucidating the molecular logic of a metabotropic glutamate receptor heterodimer

Structures of human mGlu2 and mGlu7 homo- and heterodimers

Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors

Allosteric Control of an Asymmetric Transduction in a G Protein-Coupled Receptor Heterodimer.

Molecular Recognition of Metabotropic Glutamate Receptor Type 1 (mglur1): Synergistic Understanding with Free Energy Perturbation and Linear Response Modeling

Structural basis of positive allosteric modulation of metabotropic glutamate receptor activation and internalization

Structural insights into dimerization and activation of the mGlu2–mGlu3 and mGlu2–mGlu4 heterodimers

Asymmetric activation of dimeric GABAB and metabotropic glutamate receptors

Structures of Gi-bound metabotropic glutamate receptors mGlu2 and mGlu4

Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.

G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding.

Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGlu5 dimerization

Concerted Conformational Changes Control Metabotropic Glutamate Receptor Activity.

Orthosteric and allosteric drug binding sites in the Caenorhabditis elegans mgl-2 metabotropic glutamate receptor

Distinct structure and gating mechanism in diverse NMDA receptors with GluN2C and GluN2D subunits

Dissecting Conformational Rearrangements and Allosteric Modulation in Metabotropic Glutamate Receptor Activation

Pharmacological characterisation of allosteric modulators at human mGlu5

Conformational basis of subtype-specific allosteric control of NMDA receptor gating